Decentralized Clinical Trials
Strategic Counsel For Decentralized Clinical Trial (DCT) Platform Providers, Investors, Sponsors and Supporting Entities
You’ve got a DCT platform—now it’s time to identify and smooth all the external friction points to ensure the success of your clients’ trials.
Why DCT Platform Providers, Investors, Sponsors and Supporting Entities need a healthcare innovation attorney
You know the benefits of Decentralized Clinical Trials—that’s why you’re involved in this emerging industry!
By now you’ve probably experienced the flip side to this bounty of data, diverse patient populations, and speedier clinical trials: the complex web of contracts, FDA and state regulations, and additional privacy requirements needed to keep your clinical trials above reproach.
When you’re running multiple trials at once with many supporting entities and businesses, you need tight organization, regular checkpoints, and robust safeguards to keep your clinical trials safe and on schedule.
Any of these things not operating as planned could turn into a regulatory, reputational, or revenue nightmare for your business.
That’s where we can help.
Who we serve in the DCT industry
Nixon Gwilt Law (NGL) offers nationally-recognized legal expertise and regulatory insight for DCT Platform Providers, Investors, Sponsors, and Supporting Agencies, such as:
DCT platform providers who have the app and the vision but need help with the “under the hood” complexities of running multiple clinical trials at once;
Investors in DCT platform companies who want to protect and grow their investments;
Nursing agencies, patient recruitment agencies, mobile labs, and other supporting entities that want to secure more DCT contracts;
Hospitals and health systems that seek to commercialize their IP or diversity revenue by offering hybrid clinical trial options; and
Biotech and medical device companies that are ready to explore their clinical trial options.
Supported by a team with diverse expertise in all facets of decentralized clinical trial operation—from vendor contracts to privacy to compliance to virtual care to FDA approval to logistics—Nixon Gwilt Law is well-suited to guide all the key players in the Decentralized Clinical Trials space.
[Download Available]
Where to look for friction points—aka, risk—in your DCT business
Click the link that best describes your business to download your guide.
How we work with DCT clients
NGL’s collaborative and innovative work style means you have a core unit of attorneys from our Decentralized Clinical Trials behind you, supported as needed by our entire team of healthcare innovation attorneys and diverse subject matter experts.
(Think: Remote Patient Monitoring, Remote Therapeutic Monitoring, Privacy and Security, Contracts, Virtual Care Management, Telemedicine, Telepharmacy, AI, Machine Learning , Hospitals and Health Systems, and more.)
You’ll be matched to a Lead Attorney within the team who will coordinate all your legal support throughout the Firm and serve as your main point of contact. Maintaining oversight over all this work is the Partner on Point, and underpinning it all are our technological solutions and finely-honed processes. (We were working as a cohesive virtual team with experts and clients all over the country long before the pandemic.)
What clients say about working with us
We pride ourselves on being an innovative asset for our clients—and it shows in their enthusiastic reviews of our service.
How to find out if we’re a good fit
The next step is to schedule a brief introductory meeting to discuss your needs and how we help DCT platform innovators, investors and DCT supporting entities.
Click the blue button below to tell us a little bit about your organization. Then we’ll send you a link to schedule an introductory meeting at your convenience.
It’s that easy.